“Overdose deaths could have been prevented if more people had access to methadone”: An Interview with Dr. Jeff Singer
We talked with surgeon Dr. Jeff Singer, a senior fellow at the Cato Institute, who says that industry claims about the risks of expanding access to methadone for opioid use disorder don’t add up. Here, Dr. Singer makes the case that methadone diversion is largely a symptom of poor access to this lifesaving medication.
“There’s a Lot of Pressure To Work”: An Interview with Chris Lalevee, Construction Industry Harm Reduction Advocate
We talked to Chris Lalevee, construction industry veteran and co-founder of The Alliance for Naloxone Safety in the Workplace, about the huge scale of the overdose crisis in the construction industry and his work to bring harm reduction knowledge and resources to job sites.
What the…? Safer From Harm on Why Fentanyl is in Stuff
A friend recently asked me, “Why are drug traffickers putting fentanyl in fake prescription pills? Why would they sell a deadly ingredient to their customers?”
The Latest on Harm Reduction
The Safer from Harm blog features analysis, interviews, news, and more from across the spectrum about public health and harm reduction.
Newest posts will appear first. Sign up for our newsletter to receive these straight in your inbox and learn what our coalition is up to.